Real-world predictors of 12–month intravenous abatacept retention in patients with rheumatoid arthritis in the ACTION observational study

Real-world predictors of 12–month intravenous abatacept retention in patients with rheumatoid arthritis in the ACTION observational study

Introduction An understanding of real-world predictors of abatacept retention is limited. We analysed retention rates and predictors of abatacept retention in biologic-naïve and biologic-failure patients in a 12-month interim analysis of the 2-yearAbataCepTIn rOutiNe clinical practice (ACTION) study...

Full description

Bibliographic Details
Main Authors: Xavier Mariette, Alain Cantagrel, Rieke Alten, Manuela Le Bars, Yedid Elbez, Hanns-Martin Lorenz, Mauro Galeazzi, Hubert G Nüßlein, Melanie Chartier, Christiane Rauch
Format: Article
Language:English
Published: BMJ Publishing Group 2017-12-01
Series:RMD Open
Online Access:https://rmdopen.bmj.com/content/3/2/e000538.full

Internet

https://rmdopen.bmj.com/content/3/2/e000538.full

Similar Items